Literature DB >> 2159847

Tumorigenicity and H-2 expression of papillomavirus-transformed mouse cell lines.

A Laatikainen1, H Karjalainen, H Jägerroos, H Sarkkinen, R Mäntyjärvi.   

Abstract

Tumorigenicity in immunocompetent syngeneic mice and H-2 class I antigen expression of BPV1-transformed mouse cell lines had no correlation. H-2 expression was examined using monoclonal anti-(H-2Kb) and anti-(H-2Db) antibodies in immunofluorescence staining for flow cytometry analysis and by determining the sensitivity of the cells to cytolysis by allostimulated spleen cells. Nontumorigenic cell lines were as resistant as tumorigenic cell lines to natural killer activity. The results indicate that in our model defence by natural killer cells is not a decisive factor. The results also show that instead of or in addition to H-2 class I antigens other factors (e.g. the presence or absence of virus-specific antigens) are important in determining the tumorigenicity of BPV1-transformed cell lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2159847     DOI: 10.1007/BF01744731

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

1.  Tumorigenicity of hamster and mouse cells transformed by adenovirus types 2 and 5 is not influenced by the level of class I major histocompatibility antigens expressed on the cells.

Authors:  H Haddada; A M Lewis; J A Sogn; J E Coligan; J L Cook; T A Walker; A S Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  NK susceptibility varies inversely with target cell class I HLA antigen expression.

Authors:  W J Storkus; D N Howell; R D Salter; J R Dawson; P Cresswell
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

3.  Post-transcriptional control of class I MHC mRNA expression in adenovirus 12-transformed cells.

Authors:  R T Vaessen; A Houweling; A J van der Eb
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

4.  Genetic control of the cytotoxic T cell response to SV40 tumor-associated specific antigen.

Authors:  B B Knowles; M Koncar; K Pfizenmaier; D Solter; D P Aden; G Trinchieri
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

5.  Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.

Authors:  K Taniguchi; K Kärre; G Klein
Journal:  Int J Cancer       Date:  1985-10-15       Impact factor: 7.396

6.  Characterization of a progressive tumor from C3H fibroblasts transformed in vitro with SV40 virus. Immunoresistance in vivo correlates with phenotypic loss of H-2Kk.

Authors:  L R Gooding
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

7.  Susceptibility to natural killer cell-mediated cytolysis is independent of the level of target cell class I HLA expression.

Authors:  J M Leiden; B A Karpinski; L Gottschalk; J Kornbluth
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

8.  Tumorigenicity of primary mouse fibroblasts transformed by bovine papillomavirus type 1.

Authors:  R Mäntyjärvi; H Sarkkinen; S Parkkinen; A Laatikainen; A Ryhänen; K Syrjänen
Journal:  Intervirology       Date:  1988       Impact factor: 1.763

9.  Histocompatibility antigens on murine tumors.

Authors:  R S Goodenow; J M Vogel; R L Linsk
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

10.  Modulation of the tumorigenicity of human adenovirus-12-transformed cells by interferon.

Authors:  H Hayashi; K Tanaka; F Jay; G Khoury; G Jay
Journal:  Cell       Date:  1985-11       Impact factor: 41.582

View more
  1 in total

1.  Effect of interferon gamma on the sensitivity of bovine-papilloma-virus(BPV1)-transformed cell lines to cell-mediated cytotoxicity.

Authors:  A Laatikainen; L Schultz-Suhonen; R Mäntyjärvi
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.